BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Canat L, Ataly HA, Agalarov S, Alkan I, Altunrende F. The effect of AST/ALT (De Ritis) ratio on survival and its relation to tumor histopathological variables in patients with localized renal cell carcinoma. Int Braz J Urol 2018;44:288-95. [PMID: 29211398 DOI: 10.1590/S1677-5538.IBJU.2017.0173] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Kang M, Shin SJ, Sung HH, Jeon HG, Jeong BC, Jeon SS, Lee HM, Seo SI. Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment. Dis Markers 2020;2020:8887605. [PMID: 32724485 DOI: 10.1155/2020/8887605] [Reference Citation Analysis]
2 Zhao PY, Yao RQ, Ren C, Li SY, Li YX, Zhu SY, Yao YM, Du XH. De Ritis Ratio as a Significant Prognostic Factor in Patients with Sepsis: A Retrospective Analysis. J Surg Res 2021;264:375-85. [PMID: 33848836 DOI: 10.1016/j.jss.2021.03.018] [Reference Citation Analysis]
3 Su S, Liu L, Li C, Zhang J, Li S. Prognostic Role of Pretreatment De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase Ratio) in Urological Cancers: A Systematic Review and Meta-Analysis. Front Oncol 2020;10:1650. [PMID: 33014827 DOI: 10.3389/fonc.2020.01650] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wu J, Chen L, Wang Y, Tan W, Huang Z. Prognostic value of aspartate transaminase to alanine transaminase (De Ritis) ratio in solid tumors: a pooled analysis of 9,400 patients. Onco Targets Ther 2019;12:5201-13. [PMID: 31308692 DOI: 10.2147/OTT.S204403] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
5 Janisch F, Klotzbücher T, Marks P, Kienapfel C, Meyer CP, Yu H, Fühner C, Hillemacher T, Mori K, Mostafei H, Shariat SF, Fisch M, Dahlem R, Rink M. Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors. World J Urol 2021;39:2977-85. [PMID: 33649869 DOI: 10.1007/s00345-021-03628-2] [Reference Citation Analysis]
6 Fukui S, Miyake M, Iida K, Onishi K, Hori S, Morizawa Y, Kagebayashi Y, Fujimoto K. The Preoperative Predictive Factors for Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma. Diagnostics (Basel) 2019;9:E76. [PMID: 31311108 DOI: 10.3390/diagnostics9030076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Laukhtina E, Mostafaei H, D'Andrea D, Pradere B, Quhal F, Mori K, Miura N, Schuettfort VM, Sari Motlagh R, Aydh A, Abufaraj M, Karakiewicz PI, Enikeev D, Kimura S, Shariat SF. Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC). World J Urol 2021;39:1961-8. [PMID: 32808107 DOI: 10.1007/s00345-020-03384-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Wu J, Li S, Wang Y, Hu L. Pretreatment Aspartate Aminotransferase-to-Alanine Aminotransferase (De Ritis) Ratio Predicts the Prognosis of Nonmetastatic Nasopharyngeal Carcinoma. Onco Targets Ther 2019;12:10077-87. [PMID: 31819502 DOI: 10.2147/OTT.S232563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
9 Ho HN, Do TT, Nguyen TC, Yong CS, Nguyen CN. Preparation, characterisation and in vitro/in vivo anticancer activity of lyophilised artesunate-loaded nanoparticles. Journal of Drug Delivery Science and Technology 2020;58:101801. [DOI: 10.1016/j.jddst.2020.101801] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ikeda T, Ishihara H, Takagi T, Fukuda H, Yoshida K, Iizuka J, Kobayashi H, Okumi M, Ishida H, Kondo T, Tanabe K. The De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Prognosticator in Patients With End-stage Renal Disease-associated Renal Cell Carcinoma. Clin Genitourin Cancer 2020;18:236-240.e1. [PMID: 31917171 DOI: 10.1016/j.clgc.2019.12.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wang J, Li J, Ren Y, Shi H, Rong X, Zhang X, Shao Y, Wu R, Chu M, Qiu H. Association between Alanine Aminotransferase/Aspartate Aminotransferase Ratio (AST/ALT Ratio) and Coronary Artery Injury in Children with Kawasaki Disease. Cardiol Res Pract 2020;2020:8743548. [PMID: 32274211 DOI: 10.1155/2020/8743548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
12 Laukhtina E, Pradere B, D Andrea D, Rosiello G, Luzzago S, Pecoraro A, Palumbo C, Knipper S, Karakiewicz PI, Margulis V, Quhal F, Sari Motlagh R, Mostafaei H, Mori K, Kimura S, Enikeev D, Shariat SF. Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma. Urol Oncol 2020;38:936.e7-936.e14. [PMID: 32962909 DOI: 10.1016/j.urolonc.2020.08.013] [Reference Citation Analysis]
13 Li R, Zhu WJ, Wang F, Tang X, Luo F. AST/ALT ratio as a predictor of mortality and exacerbations of PM/DM-ILD in 1 year-a retrospective cohort study with 522 cases. Arthritis Res Ther 2020;22:202. [PMID: 32950060 DOI: 10.1186/s13075-020-02286-w] [Reference Citation Analysis]